A deep monitoring microfluidic platform for label-free identification and nanodrug evaluation in lung cancer.
Real-time detection of rare cancer cells holds potential for guiding more informed treatment decisions at the bedside. However, conventional enrichment methods are limited by low sensitivity, a high risk of cell damage, and prolonged processing times. To address these challenges, this study developed an intelligent mic...